Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
about
Standards and Methodologies for Characterizing Radiobiological Impact of High-Z Nanoparticles.Perspectives of nanotechnology in minimally invasive therapy of breast cancerOptimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual countingGold nanoparticles in breast cancer treatment: promise and potential pitfalls.Selective targeting of brain tumors with gold nanoparticle-induced radiosensitizationCell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles.New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.Nanoparticles for Radiation Therapy Enhancement: the Key ParametersSpacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigenCell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.X-ray Scatter Imaging of Hepatocellular Carcinoma in a Mouse Model Using Nanoparticle Contrast Agents.The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer.Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles.Study of the biochemical effects induced by X-ray irradiations in combination with gadolinium nanoparticles in F98 glioma cells: first FTIR studies at the Emira laboratory of the SESAME synchrotron.Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.Accelerating the multifunctionalization of therapeutic nanoparticles by using a multicomponent reaction.Third generation gold nanoplatform optimized for radiation therapy.Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization.Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles.Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation.Hypoxia-targeted gold nanorods for cancer photothermal therapy.
P2860
Q26742130-B21EBD39-1A60-4E40-AB86-08121AE77FEAQ26828806-62A5DFE8-B64E-4986-8220-32B8B9C72E9FQ28247888-5FA71752-6C99-48E2-92F1-33EF74EF263EQ34079491-CA03253F-02CB-4DA8-B27E-ADCE82629F26Q34701455-7C576327-7400-4995-8A78-6A533EAE5141Q35804266-946202FC-8119-4BE3-89D2-DEE441577F21Q35821336-4C71D70B-B91D-487B-82F8-6C149404AEC7Q35824563-947AF568-9ACB-4880-8011-F31B21F74718Q35926706-2321A318-A60E-495E-BCB2-4741D9849DDFQ36136393-BD483D50-6041-4368-A885-7EFB7F90D257Q36221661-7B61E733-5FF2-4930-8BE0-C1D6BFCB70DCQ38419992-3F5815D6-D0A1-4416-8D22-DD79E9FC7DF1Q38616382-0E2EBBD1-B824-4665-916E-A4B7BD68CF0AQ38789733-1843F9CE-BC03-41B2-BB1E-6685AC08A479Q39243086-AD981DA5-2561-4BB9-8A66-B44D9FB92C75Q39375811-2C89BE0B-382A-4F72-B5B1-E9E4516485B9Q41829461-D4148625-E02A-4D3B-9ECE-48780A60B0BCQ42379031-A247EE9E-6FAF-4594-A8D4-0E0FFC511052Q50072050-140C58CF-A1D5-40A3-AA3B-3C3515969B27Q51031719-7D3C6D4C-7D7A-464A-9DA4-77938D5E703CQ54469687-9A105340-E246-4631-962B-10DA69CE3F86Q55251890-E54A9142-BFC4-4DDC-80A0-FA60CDAA52CE
P2860
Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Design and characterization of ...... ocally advanced breast cancer.
@en
Design and characterization of ...... ocally advanced breast cancer.
@nl
type
label
Design and characterization of ...... ocally advanced breast cancer.
@en
Design and characterization of ...... ocally advanced breast cancer.
@nl
prefLabel
Design and characterization of ...... ocally advanced breast cancer.
@en
Design and characterization of ...... ocally advanced breast cancer.
@nl
P2093
P356
P1476
Design and characterization of ...... ocally advanced breast cancer.
@en
P2093
Brian Keller
Eli Lechtman
Jean-Philippe Pignol
Niladri Chattopadhyay
Raymond M Reilly
Reina Bendayan
P304
P356
10.1021/MP100207T
P407
P50
P577
2010-11-08T00:00:00Z